Market Share of Candidiasis Therapeutics Industry
The Candidiasis Therapeutics market is competitive and consists of several major players. In terms of market share, a few major players dominate the market. Some prominent players launch new products, while others engage in product development and clinical trials. The competitive landscape includes an analysis of several companies which hold most of the market shares and are well known. Basilea Pharmaceutica Ltd, Astellas Pharma Inc., SCYNEXIS, Inc., NovaDigm Therapeutics, Mycovia Pharmaceuticals, Inc., Pfizer Inc, and Viatris Inc., among others.
Candidiasis Therapeutics Market Leaders
Basilea Pharmaceuticals
Astellas
SCYNEXIS, Inc.
Pfizer Inc.
Viatris Inc.
*Disclaimer: Major Players sorted in no particular order
